AngioDynamics (ANGO) Tops Q1 EPS by 2c, Offers Guidance

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $75.7 million versus the consensus estimate of $72.7 million.

GUIDANCE:

AngioDynamics sees FY2026 EPS of ($0.23)-($0.33), versus the consensus of ($0.31). AngioDynamics sees FY2026 revenue of $308-313 million, versus the consensus of $307.5 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• CalPrivate Bank names Andra Frazier as chief credit officer